Stock screener
All disclosures →
EDGAR →
PCVX
Conviction 92HealthcareScan · Mon, Aug 10, 2026Bullish harami
PCVX$58.29+0.37%
ResistanceSupportVol 14Insider sellCongress buyCongress sell2
6
4
2
Vol MA14 1.12M
May 11May 28Jun 16Jul 6Jul 23Aug 10
Price58.29
Change+0.37%
Gap+0.20%
Rel volume2.72×
Avg volume1.06M
Avg $ vol59.67M
SMA 2055.88
SMA 5053.85
SMA 20052.46
Price vs 50+8.23%
Price vs 200+11.10%
MA stackbullish
50/200 cross—
Supertrendup · 51.64
RSI (14)57
MACD hist0.24
MACD crossbull · 2d
Stoch %K / %D76 / 83
ADX (14)23
+DI / −DI25 / 11
RSI divergence—
MACD divergence—
ATR %+4.26%
ADR %4.23%
52w high63.04
52w low29.67
From 52w high-7.54%
Above 52w low+96.44%
New 52w highNo
SqueezeOn · 3d
Bollinger width11.02%
%B0.89
Donchian pos76.46%
Donchian high60.08
Donchian low52.47
AVWAP (52w high)55.17
vs AVWAP high+5.66%
AVWAP (52w low)48.09
vs AVWAP low+21.20%
OBV trendFlat
Chaikin MF (20)-0.06
Today vs 20d2.72×
Avg vol (14d)1.12M
Avg vol (20d)1.06M
Avg $ vol (20d)59.67M
Market cap8.67B
RS 3m (vs SPY)+7.10%
RS 6m (vs SPY)-6.40%
RS line new highNo
Trend template7/8
Technical rank66.9
1 week+8.88%
1 month+0.13%
3 months+9.95%
6 months+3.80%
1 year+94.22%
YTD+25.45%
P/E-11.31
P/B3.14
P/S—
P/FCF-12.96
EPS-5.63
Div yield—
ROE-27.80%
ROA-24.43%
Debt/Eq—
Current5.72
EV/EBITDA-9.36
Gross margin—
Net margin—
Rev growth—
EPS growth-65.25%
Price target114.33
Target upside96.16%
Analyst ratingBuy
Institutional117.81%
Ent. value8.49B
Revenue—
Net income-284.3M
Gross profit—
Free cash flow-669.29M
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
ExchangeNasdaq
Shares out144.4M
Employees507
ListedFri, Jun 12, 2020
Free float126.82M
Float %87.8%
Short interest14.23M
Days to cover12.4d
Short volume71.9%
Squeeze score82 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$1.97 vs −$1.47
Last surprise-34.0% miss
Setup gradeA+
Conviction92 / 100
Pattern quality—
Tech rank66.9 / 100
Group rank86 / 100 · Leading
Status lane—
Setup direction—
Pattern family
Resistance—
Support—
Days since event—
Candle confirmBullish harami
News sentiment—
Financials as of Tue, Jun 30, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in PCVX · 6 recent
| Member | Side | Amount | Traded | Filed | PTR |
|---|---|---|---|---|---|
Gilbert Cisneros house · CA · traded 2026-05-13 | Buy | $1K–$15K | 2026-05-13 | 2026-06-05 | |
Gilbert Cisneros house · CA · traded 2026-05-12 | Buy | $1K–$15K | 2026-05-12 | 2026-06-05 | |
Gilbert Cisneros house · D · CA · traded 2025-04-14 | Buy | $1K–$15K | 2025-04-14 | 2025-05-06 | |
Gilbert Cisneros house · D · CA · traded 2025-04-15 | Buy | $1K–$15K | 2025-04-15 | 2025-05-06 | |
Gilbert Cisneros house · D · CA · traded 2025-04-28 | Buy | $1K–$15K | 2025-04-28 | 2025-05-06 | |
 Jefferson Shreve house · R · IN · traded 2025-03-05 | Sell | $15K–$50K | 2025-03-05 | 2025-04-11 |
Insider activity
SEC Form 4 transactions in PCVX · 3 buys · 7 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Dhaliwal Harpreet S. Chief Technical Ops Officer · Common Stock · 2026-08-05 | Exercise | 17K | $421K | 2026-08-05 | 2026-08-05 |
Dhaliwal Harpreet S. Chief Technical Ops Officer · Common Stock · 2026-08-05 | Sell | 17K | $935K | 2026-08-05 | 2026-08-05 |
Dhaliwal Harpreet S. Chief Technical Ops Officer · Stock Option (right to buy) · 2026-08-05 | Exercise | 17K | — | 2026-08-05 | 2026-08-05 |
GUGGENHIME ANDREW PRESIDENT AND CFO · Common Stock · 2026-08-03 | Exercise | 10K | $54K | 2026-08-03 | 2026-08-05 |
GUGGENHIME ANDREW PRESIDENT AND CFO · Common Stock · 2026-08-03 | Sell | 6.96K | $374K | 2026-08-03 | 2026-08-05 |
GUGGENHIME ANDREW PRESIDENT AND CFO · Common Stock · 2026-08-03 | Sell | 3.04K | $165K | 2026-08-03 | 2026-08-05 |
GUGGENHIME ANDREW PRESIDENT AND CFO · Stock Option (right to buy) · 2026-08-03 | Exercise | 10K | — | 2026-08-03 | 2026-08-05 |
PICKERING GRANT CHIEF EXECUTIVE OFFICER · Common Stock · 2026-07-27 | Exercise | 16.2K | $33K | 2026-07-27 | 2026-07-28 |
PICKERING GRANT CHIEF EXECUTIVE OFFICER · Common Stock · 2026-07-27 | Sell | 11.78K | $654K | 2026-07-27 | 2026-07-28 |
PICKERING GRANT CHIEF EXECUTIVE OFFICER · Common Stock · 2026-07-27 | Sell | 4.42K | $247K | 2026-07-27 | 2026-07-28 |
SEC filings
EDGAR filings in PCVX · 10 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.